These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21606082)

  • 1. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis.
    Giannarelli C; Cimmino G; Connolly TM; Ibanez B; Ruiz JM; Alique M; Zafar MU; Fuster V; Feuerstein G; Badimon JJ
    Eur Heart J; 2012 Jan; 33(2):264-73. PubMed ID: 21606082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
    Bai W; Zheng X; Zhou L; Li H
    Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis.
    Ibanez B; Vilahur G; Cimmino G; Speidl WS; Pinero A; Choi BG; Zafar MU; Santos-Gallego CG; Krause B; Badimon L; Fuster V; Badimon JJ
    J Am Coll Cardiol; 2008 Mar; 51(11):1104-9. PubMed ID: 18342230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging.
    Corti R; Osende JI; Fallon JT; Fuster V; Mizsei G; Jneid H; Wright SD; Chaplin WF; Badimon JJ
    J Am Coll Cardiol; 2004 Feb; 43(3):464-73. PubMed ID: 15013132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type).
    Ibanez B; Giannarelli C; Cimmino G; Santos-Gallego CG; Alique M; Pinero A; Vilahur G; Fuster V; Badimon L; Badimon JJ
    Atherosclerosis; 2012 Jan; 220(1):72-7. PubMed ID: 22030095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect.
    Gómez-Garre D; Muñoz-Pacheco P; González-Rubio ML; Aragoncillo P; Granados R; Fernández-Cruz A
    Br J Pharmacol; 2009 Apr; 156(8):1218-27. PubMed ID: 19222481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypercholesterolemic and antioxidant efficacies of zerumbone on the formation, development, and establishment of atherosclerosis in cholesterol-fed rabbits.
    Hemn HO; Noordin MM; Rahman HS; Hazilawati H; Zuki A; Chartrand MS
    Drug Des Devel Ther; 2015; 9():4173-208. PubMed ID: 26347047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
    Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
    J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.
    Quinet EM; Basso MD; Halpern AR; Yates DW; Steffan RJ; Clerin V; Resmini C; Keith JC; Berrodin TJ; Feingold I; Zhong W; Hartman HB; Evans MJ; Gardell SJ; DiBlasio-Smith E; Mounts WM; LaVallie ER; Wrobel J; Nambi P; Vlasuk GP
    J Lipid Res; 2009 Dec; 50(12):2358-70. PubMed ID: 19318684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin reduces expression and activity of lipoprotein-associated phospholipase A(2) in the aorta of hypercholesterolaemic atherosclerotic rabbits.
    Qiao Z; Ren J; Chen H
    J Int Med Res; 2009; 37(4):1029-37. PubMed ID: 19761685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin.
    Vucic E; Calcagno C; Dickson SD; Rudd JH; Hayashi K; Bucerius J; Moshier E; Mounessa JS; Roytman M; Moon MJ; Lin J; Ramachandran S; Tanimoto T; Brown K; Kotsuma M; Tsimikas S; Fisher EA; Nicolay K; Fuster V; Fayad ZA
    JACC Cardiovasc Imaging; 2012 Aug; 5(8):819-28. PubMed ID: 22897996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Si-Miao-Yong-An on the stability of atherosclerotic plaque in a diet-induced rabbit model.
    Peng L; Li M; Xu YZ; Zhang GY; Yang C; Zhou YN; Li LJ; Zhang JP
    J Ethnopharmacol; 2012 Aug; 143(1):241-8. PubMed ID: 22750436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL (High-Density Lipoprotein) Remodeling and Magnetic Resonance Imaging-Assessed Atherosclerotic Plaque Burden: Study in a Preclinical Experimental Model.
    Ben-Aicha S; Casaní L; Muñoz-García N; Joan-Babot O; Peña E; Aržanauskaitė M; Gutierrez M; Mendieta G; Padró T; Badimon L; Vilahur G
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2481-2493. PubMed ID: 32847390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Atherosclerosis Progression, Intimal Hyperplasia, and Oxidative Stress by Simvastatin and Ivabradine May Reduce Thoracic Aorta's Stiffness in Hypercholesterolemic Rabbits.
    Koniari I; Mavrilas D; Apostolakis E; Papadimitriou E; Papadaki H; Papalois A; Poimenidi E; Xanthopoulou I; Hahalis G; Alexopoulos D
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):412-22. PubMed ID: 26612090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy.
    Zhang L; Liu Y; Lu XT; Wu YL; Zhang C; Ji XP; Wang R; Liu CX; Feng JB; Jiang H; Xu XS; Zhao YX; Zhang Y
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2004-14. PubMed ID: 19801495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
    Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
    Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptors as potential therapeutic targets in atherosclerosis.
    Zhu Y; Li Y
    Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of simvastatin on NF-kappaB-DNA binding activity and monocyte chemoattractant protein-1 expression in a rabbit model of atherosclerosis.
    Yang X; Wang L; Zeng H; Dubey L; Zhou N; Pu J
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):194-8. PubMed ID: 16850745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
    Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.